Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm	Recruiting	Phase 1	2026-06-01		NCT03370406

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Melissa Pugliano-Mauro	3
National Cancer Institute (NCI)	3015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
St. Margaret Hospital Dermatology	Pittsburgh	United States	1

Clinical trials